학술논문

Relapsed or refractory chronic lymphocytic leukemia retreated with rituximab in daily practice: final results of the PERLE study.
Document Type
Letter to the Editor
Source
Leukemia & Lymphoma. Jun2019, Vol. 60 Issue 6, p1563-1567. 5p.
Subject
*CHRONIC lymphocytic leukemia
*PROGRESSION-free survival
Language
ISSN
1042-8194